Gracial ProdMonograph_cover - epgonline.org
Gracial ProdMonograph_cover - epgonline.org
Gracial ProdMonograph_cover - epgonline.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Pharmacokinetics<br />
ENG mainly<br />
bound to<br />
albumin and<br />
SHBG<br />
2.2 Ethinylestradiol (EE)<br />
Following oral administration of <strong>Gracial</strong>, ethinylestradiol (EE) is<br />
absorbed within 1.5 hours (Jung-Hoffman et al 1992) and<br />
then distributed throughout the body. The absolute<br />
bioavailability of EE after multiple dosing of a DSG/EE<br />
combination has been calculated as approximately 59% (Back<br />
et al 1987). Plasma EE is 98.5% protein bound, almost<br />
entirely to albumin (Kuhl 1990).<br />
The metabolism of EE involves cytochrome P450-mediated<br />
hydroxylation, with 2-hydroxy-EE and 2-methoxy-EE as the<br />
major metabolites (Purba et al 1987).<br />
Half-life EE<br />
29 hours<br />
EE is eliminated from the body principally as conjugated<br />
metabolites and the elimination half-life has been calculated<br />
at about 29 hours (Bergink et al 1990). Excretion occurs via<br />
urine and feces at a ratio of 1:1.6 (Speck et al 1976).<br />
EE pg/ml)<br />
100<br />
50<br />
Day 7<br />
2 4 6 8 12 24 h<br />
EE (pg/ml)<br />
100<br />
50<br />
Day 22<br />
2 4 6 8 12 24 h<br />
Fig. 5: Ethinylestradiol serum concentration on days<br />
7 and 22 of <strong>Gracial</strong> administration<br />
Jung-Hoffmann et al 1992<br />
8